tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

KROS Stock Latest News

Keros Therapeutics CEO to Speak at Major Conferences
Company AnnouncementsKeros Therapeutics CEO to Speak at Major Conferences
6d ago
8K
KROS
Keros Therapeutics Hold Rating: Uncertainty in KER-065 Development and Cibotercept Safety Concerns
PremiumRatings
Keros Therapeutics Hold Rating: Uncertainty in KER-065 Development and Cibotercept Safety Concerns
7d ago
KROS
Keros Therapeutics Strengthens Financial Position Amid R&D Expansion
PremiumCompany Announcements
Keros Therapeutics Strengthens Financial Position Amid R&D Expansion
8d ago
KROS
Keros Therapeutics reports Q4 EPS ($1.14) vs. ($1.34) last year
PremiumThe Fly
Keros Therapeutics reports Q4 EPS ($1.14) vs. ($1.34) last year
8d ago
KROS
Keros Therapeutics CEO to Speak at Biotech Conference
PremiumCompany Announcements
Keros Therapeutics CEO to Speak at Biotech Conference
1M ago
8K
KROS
Keros Therapeutics announces effectiveness of global agreement with Takeda
PremiumThe FlyKeros Therapeutics announces effectiveness of global agreement with Takeda
1M ago
TAK
KROS
Keros Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
Premium
The Fly
Keros Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
1M ago
KROS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ANIX
ERNA
Keros Therapeutics downgraded at Wedbush after removing PAH, obesity programs
PremiumThe Fly
Keros Therapeutics downgraded at Wedbush after removing PAH, obesity programs
2M ago
KROS
Keros Therapeutics downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Keros Therapeutics downgraded to Neutral from Outperform at Wedbush
2M ago
KROS
Keros Therapeutics price target lowered to $15 from $40 at Piper Sandler
PremiumThe Fly
Keros Therapeutics price target lowered to $15 from $40 at Piper Sandler
2M ago
KROS
Keros Therapeutics price target lowered to $41 from $44 at Scotiabank
PremiumThe Fly
Keros Therapeutics price target lowered to $41 from $44 at Scotiabank
2M ago
TAK
KROS
Keros Therapeutics price target lowered to $23 from $63 at Oppenheimer
PremiumThe FlyKeros Therapeutics price target lowered to $23 from $63 at Oppenheimer
2M ago
KROS
Keros Therapeutics price target lowered to $32 from $33 at BofA
Premium
The Fly
Keros Therapeutics price target lowered to $32 from $33 at BofA
2M ago
KROS
Big banks report Q4 beats, QXO proposes to buy Beacon: Morning Buzz
Premium
The Fly
Big banks report Q4 beats, QXO proposes to buy Beacon: Morning Buzz
2M ago
C
S
Morning Movers: Wells Fargo and Citi gain following Q4 earnings
PremiumThe Fly
Morning Movers: Wells Fargo and Citi gain following Q4 earnings
2M ago
C
BK
Keros Therapeutics voluntarily halts all dosing of Phase 2 TROPOS trial
PremiumThe Fly
Keros Therapeutics voluntarily halts all dosing of Phase 2 TROPOS trial
2M ago
KROS
Keros Therapeutics Updates on Clinical Trials and Safety
PremiumCompany Announcements
Keros Therapeutics Updates on Clinical Trials and Safety
2M ago
8K
KROS
Keros Therapeutics price target lowered to $43 from $100 at Truist
PremiumThe Fly
Keros Therapeutics price target lowered to $43 from $100 at Truist
2M ago
TAK
KROS
Keros Therapeutics price target lowered to $63 from $102 at Oppenheimer
PremiumThe FlyKeros Therapeutics price target lowered to $63 from $102 at Oppenheimer
3M ago
KROS
Keros Therapeutics downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
Keros Therapeutics downgraded to Neutral from Buy at Guggenheim
3M ago
KROS
Keros Therapeutics price target lowered to $44 from $77 at Scotiabank
Premium
The Fly
Keros Therapeutics price target lowered to $44 from $77 at Scotiabank
3M ago
KROS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >